(Press-News.org) U.S. outpatient prescriptions for hydroxychloroquine and ivermectin increased 2- to 10-fold above pre-pandemic rates, respectively, to treat COVID-19, despite strong evidence disproving their effectiveness, new UCLA-led research shows.
Nearly three million COVID-related prescriptions were issued in the three and a half years between January 30, 2020 and June 30, 2023, totaling $272 million in estimated spending. Usage was three times higher among adults aged 65 and older compared with those aged 18 to 64. Ivermectin use in particular was higher among people living in the most socially vulnerable neighborhoods and markedly higher in the Southern United States.
These findings, published in the peer-reviewed journal Health Affairs, may inform future policies aimed at reducing the harms caused by reliance on non-evidence-based treatments, especially among vulnerable communities.
“Our findings underscore the urgent need for policy reforms to combat misinformation and mistrust in scientific institutions. Eliminating undue industry influence in government, enhancing transparency around scientific uncertainty, and earmarking public funding for clinical trials of new drugs are good places to start,” said Dr. John Mafi, associate professor-in-residence in the UCLA Division of General Internal Medicine and Health Services Research and the study’s senior author.
The researchers used insurance claims listed in the Milliman MedInsight Emerging Experience Research Database for 8.1 million patients from across all 50 states to assess utilization and spending for the two medications from January 30, 2020 to June 30, 2023.
Among the findings were:
Nearly three million COVID-related prescriptions in outpatient settings during the study period, totaling $272 million.
Hydroxychloroquine use peaked in March 2020 to 133% of pre-pandemic rates
Ivermectin use surged in 2020 and throughout 2021, and by August 2021 peaked at more than 10 times higher than pre-pandemic rates
After FDA-authorized COVID-19 medications (e.g., Paxlovid) became available, ivermectin and hydroxychloroquine use dropped by 93% in outpatient settings from March 1, 2022 to June 30, 2023.
Of the estimated $272 million spent for COVID-19-related hydroxychloroquine and ivermectin, approximately $18 million was spent after March 2022 when FDA-authorized COVID medications became available.
Limited availability of COVID-19 medications does not appear to explain the wide geographic variation in ivermectin prescribing, particularly in the South.
There are some limitations to the study. The cohort included what is called a “convenience sample,” meaning that the researchers used data from a group that was easy, or convenient, to sample rather than randomly chosen. While the findings may thus not be generalizable, prior work confirms that the demographics in the dataset the researchers used reflect the U.S. population as a whole. In addition, medications that patients obtained without insurance or a prescription were not included in the analysis; variations in the price of ivermectin and hydroxychloroquine around the country may not have been captured in the researcher’s spending estimates for the drugs. Additionally, the researchers attributed the increase in the drugs’ usage rate to their utilization for COVID treatment although not all the claims in the data noted that.
“To our knowledge, this is the first study to report on trends in ivermectin and hydroxychloroquine utilization and spending in U.S. outpatient settings throughout the entire COVID-19 pandemic. This utilization represents wasteful spending and potentially avoidable harm. Our findings highlight the complex drivers of non-evidence based care, particularly in a time of uncertainty and distress. Multilevel efforts to enhance equitable, high-value care while minimizing non-evidence-based care are needed,” said Dr. Michelle Rockwell, the study’s lead author and assistant professor of family & community medicine at Virginia Tech Carilion School of Medicine.
Study co-authors included Sitaram Vangala and Dr. Katherine Kahn of UCLA; Jonathan Cantor and Cheryl Damberg of RAND Corporation; Michael Hadfield, Dale Skinner and Melody Craff of Milliman MedInsight, and Dr. A. Mark Fendrick of the University of Michigan.
This study was funded by the Commonwealth Fund, the National Center for Advancing Translational Sciences, National Institutes of Health (KL2TR003016 and UL1TR003015), and the National Institute on Aging/National Institutes of Health (K76AG064392).
END
Ivermectin, hydroxychloroquine prescriptions during the COVID-19 pandemic soared far above pre-pandemic levels
2025-02-20
ELSE PRESS RELEASES FROM THIS DATE:
3D lung model raises the bar for research
2025-02-20
Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in the lungs at the correct dosage.
How effectively this works can get complicated, depending on the drug, delivery method and patient. This is because it is difficult to predict just how much medicine gets in and where it goes in the lung. Similar challenges exist when thinking about measuring an ...
Lehigh Engineering faculty named Senior Members of the National Academy of Inventors
2025-02-20
Six Lehigh University professors have been named Senior Members of the National Academy of Inventors. The 2025 cohort comprises 162 academic inventors representing 64 NAI Member Institutions across the United States. Collectively, they are named inventors on over 1200 U.S. patents.
“This year’s class comes from a multitude of impressive fields and research backgrounds from across the world,” said NAI President Paul R. Sanberg. “We applaud their pursuit of commercialization to ensure their groundbreaking technologies ...
Researchers outline new approach for better understanding animal consciousness
2025-02-20
A team of researchers has outlined a new approach for better understanding the depths of animal consciousness, a method that may yield new insights into the similarities and differences among living organisms.
The essay, which appears in the journal Science, describes a “marker method” that scientists can use to assess animal consciousness. It involves identifying behavioral and anatomical features associated with conscious processing in humans and searching for similar properties in nonhumans. By making progress in the science of animal consciousness, the authors propose, we can make progress on foundational questions about the nature of consciousness, ...
Bioinspired robot collectives that can act like solids or fluids on demand
2025-02-20
Inspired by the cooperation of cells in tissues, researchers have developed a robotic collective system capable of transitioning between rigid and solid structures that can also support hundreds of times its own weight. The advancement overcomes a core challenge in the development of so-called “robotic materials” – cohesive networks of individual robotic units that function as a single dynamic, adaptive structure. Realizing these systems presents a fundamental challenge: this “material” must at once be strong and stiff enough to support loads, ...
AI-assisted diagnosis for immunological disease
2025-02-20
A novel machine learning framework – Mal-ID – can decipher an individual’s immune system’s record of past infections and diseases, according to a new study, providing a powerful tool with the potential for diagnosing autoimmune disorders, viral infections, and vaccine responses with precision. Traditional clinical diagnostic methods for autoimmune diseases or other immunological pathologies tend to rely on a combination of physical examination, patient history, and various laboratory testing for cellular or molecular abnormalities – a lengthy process often complicated by initial misdiagnoses and ambiguous systems. These approaches make limited use of data from ...
A new approach for breaking plastic waste down to monomers
2025-02-20
Researchers have reported a method for breaking down commercial polymers like Plexiglass into monomers, a form more desirable for reuse. This could help alleviate the growing plastic waste stream. Most current plastic recycling methods rely on macroscopic mechanical shredding, cleaning and reprocessing. As a result, the properties degrade relative to the virgin polymer. Chemical decomposition to the original monomer would enable more thorough purification and then repolymerization to restore ideal performance. Here, Hyun Suk Wang and colleagues report the discovery that in dichlorobenzene solvent, violet light irradiation ...
High-performance computing at a crossroads
2025-02-20
High-performance computing (HPC) systems – advanced computing ensembles that harness deliver massive processing power – are used for a range of applications, and the demand for them has increased with the rise of generative artificial intelligence (AI). However, for both traditional uses and to advance the power of AI, technical advances in HPC are greatly needed, say Ewa Deelman and colleagues in a Policy Forum. “With international competition for leadership in computing intensifying, without a renewed commitment, ...
Chemists find greener path to making key industrial chemical
2025-02-20
Scientists have discovered a potentially greener way to produce a crucial industrial chemical used to make many everyday products from plastics and textiles to antifreeze and disinfectants, according to a new study published in Science and co-authored by Tulane University chemical engineer Matthew Montemore.
The breakthrough could significantly reduce greenhouse gas emissions from the manufacture of ethylene oxide, which has an estimated $40 billion global market. The current production process requires chlorine, which is toxic and ...
Giant X-ray facility shows that magnets can reduce flaws in 3D printed components
2025-02-20
Safety critical components for aircraft and Formula 1 racing cars could one day be 3D printed via a new technique, developed by researchers at UCL and the University of Greenwich, that substantially reduces imperfections in the manufacturing process.
The technique was developed after the team used advanced X-ray imaging to observe the causes of imperfections that formed in complex 3D printed metal alloy components. If this technique becomes widely deployed it could make a range of these components, from artificial hip joints to aircraft parts, stronger and more durable.
The study, published in Science, observes the forces at play during ...
Cooling materials – Out of the 3D printer
2025-02-20
Rapid, localized heat management is essential for electronic devices and could have applications ranging from wearable materials to burn treatment. While so-called thermoelectric materials convert temperature differences to electrical voltage and vice versa, their efficiency is often limited, and their production is costly and wasteful. In a new paper published in Science, researchers from the Institute of Science and Technology Austria (ISTA) used a 3D printing technique to fabricate high-performance thermoelectric materials, reducing production costs significantly.
Thermoelectric coolers, also called solid-state ...